About 111
111 (NASDAQ:YI) is a digital healthcare platform aiming to revolutionize the medical and pharmaceutical industry in China. By integrating online and offline resources, 111 is dedicated to making healthcare more accessible and efficient for its customers. The company operates across several key areas including telemedicine consultations, an online pharmacy, and smart supply chain solutions. Their objective is to leverage technology to improve the healthcare experience, ensuring patients can receive reliable medical consultations and have their prescriptions conveniently fulfilled online. Through strategic partnerships and innovative services, 111 is committed to building a comprehensive healthcare ecosystem that addresses the needs of millions of individuals across China.
Snapshot
Operations
Products and/or services of 111
- Online Pharmaceutical Platform offering a one-stop-shop for medications, health products, and medical services to consumers.
- B2B Supply Chain Solutions catering to pharmaceutical companies, enhancing efficiency in drug distribution.
- Cloud-based Services for Pharmacies, integrating digital tools and data analytics to improve operations and customer engagement.
- Telehealth Services providing virtual consultations and online prescriptions, expanding access to healthcare.
- Digital Marketing Solutions designed for pharmaceutical and healthcare providers to increase brand visibility and patient outreach.
- Smart Healthcare Initiatives leveraging AI and big data to offer personalized health recommendations and services.
111 executive team
- Dr. Gang Yu Ph.D.Co-Founder & Executive Chairman
- Mr. Junling LiuCo-Founder, Acting CFO, Chairman & CEO
- Mr. Haihui WangCo-Chief Operating Officer
- Mr. Pengcheng ZhuCo-Chief Operating Officer
- Monica MuIR Director
- Mr. Anfeng GuoChief Innovation Officer
- Mr. Alex LiuFinance Director